Multiplex Immunofluorescence: A Powerful Tool in Cancer Immunotherapy
International Journal of Molecular Sciences · 04.02.2023 · 24 (4) · 3086
DOI: 10.3390/ijms24043086 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 04.02.2023. Verfasst von Wenjie Sheng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology and Obstetrics, Medical Faculty, Justus-Liebig-University Giessen, Klinikstr. 33, 35392 Giessen, Germany. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit wurde bisher 102-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Traditional immunohistochemistry (IHC) has already become an essential method of diagnosis and therapy in cancer management. However, this antibody-based technique is limited to detecting a single marker per tissue section. Since immunotherapy has revolutionized the antineoplastic therapy, developing new immunohistochemistry strategies to detect multiple markers simultaneously to better understand tumor environment and predict or assess response to immunotherapy is necessary and urgent. Multiplex immunohistochemistry (mIHC)/multiplex immunofluorescence (mIF), such as multiplex chromogenic IHC and multiplex fluorescent immunohistochemistry (mfIHC), is a new and emerging technology to label multiple biomarkers in a single pathological section. The mfIHC shows a higher performance in cancer immunotherapy. This review summarizes the technologies, which are applied for mfIHC, and discusses how they are employed for immunotherapy research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gynecology and Obstetrics, Medical Faculty, Justus-Liebig-University Giessen, Klinikstr. 33, 35392 Giessen, Germany.
- Institute for Parasitology, Faculty of Veterinary Medicine, Justus Liebig University Giessen, 35392 Giessen, Germany.
ORCID-Profile: T M Mohiuddin, Franco H Falcone, Ivo Meinhold-Heerlein
Zitieren
APA
Sheng, W., Zhang, C., Mohiuddin, T. M., Al-Rawe, M., Zeppernick, F., Falcone, F. H., Meinhold-Heerlein, I., & Hussain, A. F. (2023). Multiplex Immunofluorescence: A Powerful Tool in Cancer Immunotherapy. International Journal of Molecular Sciences, 24(4), 3086. https://doi.org/10.3390/ijms24043086
Vancouver
Sheng W, Zhang C, Mohiuddin TM, Al-Rawe M, Zeppernick F, Falcone FH, et al. Multiplex Immunofluorescence: A Powerful Tool in Cancer Immunotherapy. International Journal of Molecular Sciences. 2023;24(4):3086. doi:10.3390/ijms24043086
BibTeX
@article{Sheng2023,
author = {Sheng, Wenjie and Zhang, Chaoyu and Mohiuddin, T M and Al-Rawe, Marwah and Zeppernick, Felix and Falcone, Franco H and Meinhold-Heerlein, Ivo and Hussain, Ahmad Fawzi},
title = {Multiplex Immunofluorescence: A Powerful Tool in Cancer Immunotherapy},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {4},
pages = {3086},
doi = {10.3390/ijms24043086}
}
EUVIMED